AdventHealth’s Dr. Stephanie Compton Featured in ACS Highlight on Diet and Cancer Treatment

We’re proud to announce that Stephanie Compton, PhD, a valued post‑doctoral researcher at the AdventHealth Research Institute, was recently featured by the American Cancer Society for her contributions to a study exploring the link between diet quality and chemotherapy-induced peripheral neuropathy (CIPN) in colon cancer patients.

In the highlighted research, patients undergoing chemotherapy with oxaliplatin experienced fewer and less severe CIPN symptoms when following a high-quality diet—particularly one rich in vegetables and low in red/processed meats and sugary beverages.

Dr. Compton’s work was instrumental in analyzing dietary data and helping uncover the protective role nutrition can play during cancer treatment. Her efforts support a growing body of evidence that simple dietary improvements may enhance patient comfort and outcomes during therapy.

We celebrate Dr. Compton for her impactful research and continued dedication to advancing cancer care.

Click below to read the full article.

Recent News

12 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
News

Understanding Hypoglycemia and the CLEAR Study

The CLEAR Study is a groundbreaking, international research effort funded by the NIH that aims to help people with Type 1 diabetes (T1D) who can no longer sense when their blood sugar is dangerously...

News

Did you know? Women, Hormones, and Heart Risk

Heart disease is often thought of as a “man’s disease,” but it remains the leading cause of death for women in the United States. We asked Katie Love, MD, MSc, an investigator at the AdventHealth...

News

Meet the Team: Dr. Katie Love, MD

Meet Dr. Katie Love an Endocrinologist and Associate Investigator at the AdventHealth Translational Research Institute. Dr. Love was diagnosed with Type 1 diabetes at just four years old and decided...